Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients
- PMID: 11370816
Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients
Abstract
Although its role and importance is debated, Immunoscintigraphy (IS) remains a popular technique in Malignant Melanoma (MM) follow-up for postoperative assessment. Between April 1990 and December 1996, 287 consecutive patients underwent 650 IS examinations at our Department. Only data on 114 patients, operated up to December 1993, with a follow-up of at least 7 years are given here. IS results were compared to physical examination, to other imaging modalities and, where available, to histology. IS specificity and sensivity, concerning detection of melanoma metastases in lymph nodes, skin, brain, lung, visceral sites and bone, ranged from 37.5% and 22% to 100%. Our results indicate a high diagnostic accuracy of IS only for lymph node examination, but not for other possible locations of melanoma metastases. In our experience IS cannot be recommended for staging of melanoma patients, and should only be used in association with other imaging modalities.
Similar articles
-
Rare clinical experiences for surgical treatment of melanoma with osseous metastases in Taiwan.BMC Musculoskelet Disord. 2007 Jul 25;8:70. doi: 10.1186/1471-2474-8-70. BMC Musculoskelet Disord. 2007. PMID: 17650346 Free PMC article.
-
Detection of recurrent malignant melanoma with 99mTc-MIBI scintigraphy.Melanoma Res. 1998 Aug;8(4):355-60. doi: 10.1097/00008390-199808000-00009. Melanoma Res. 1998. PMID: 9764811
-
Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.Melanoma Res. 2019 Feb;29(1):53-58. doi: 10.1097/CMR.0000000000000528. Melanoma Res. 2019. PMID: 30362976
-
[Immunoscintigraphy of malignant melanoma].Pathol Biol (Paris). 1990 Oct;38(8):866-9. Pathol Biol (Paris). 1990. PMID: 2274393 Review. French.
-
Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.Expert Rev Anticancer Ther. 2006 Jul;6(7):1105-10. doi: 10.1586/14737140.6.7.1105. Expert Rev Anticancer Ther. 2006. PMID: 16831081 Review.
MeSH terms
LinkOut - more resources
Medical
Miscellaneous